+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pneumonia Drug"

From
From
From
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2020 - Product Thumbnail Image

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 187 Pages
  • Global
From
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2020 - Product Thumbnail Image

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 207 Pages
  • Global
From
Pneumonia Treatment Drugs Companies in China - Product Thumbnail Image

Pneumonia Treatment Drugs Companies in China

  • Report
  • November 2023
  • 80 Pages
  • China
From
Pneumonia Treatment Drugs Markets in China - Product Thumbnail Image

Pneumonia Treatment Drugs Markets in China

  • Report
  • November 2023
  • 242 Pages
  • China
From
Loading Indicator

The Pneumonia Drug market is a subset of the larger Respiratory Drugs market. It includes drugs used to treat bacterial, viral, and fungal pneumonia, as well as other respiratory infections. These drugs are typically administered orally, intravenously, or intramuscularly, depending on the severity of the infection. Commonly prescribed drugs include antibiotics, antivirals, antifungals, and corticosteroids. In addition, some drugs are used to reduce inflammation and improve breathing. The Pneumonia Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck, Sanofi, AstraZeneca, and Novartis. Show Less Read more